Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| VERAVera Therapeutics, Inc. | Leerink Partners | Initiated | Market Perform | $34 | Oct 12 |
| OBXObsidian Therapeutics, Inc. | Leerink Partners | Initiated | Outperform | $32 | Sep 22 |
| VTRSViatris Inc. | Leerink Partners | Initiated |
Showing the 4 most recent actions over 90 days.
| Outperform |
| $20 |
| Sep 9 |
| TEVATeva Pharmaceutical Industries Limited | Leerink Partners | Initiated | Outperform | $45 | Sep 9 |